Sustained hyperglycemia specifically targets translation of mRNAs for insulin secretion
Journal of Clinical Investigation · 30.11.2023 · 134 (3)
DOI: 10.1172/jci173280 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Investigation, online erschienen am 30.11.2023. Verfasst von Abigael Cheruiyot und 6 weiteren Autor:innen. Hauptthemen laut MEDLINE: Hyperglycemia, Insulin-Secreting Cells, Pancreatic Neoplasms, Islets of Langerhans. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 64 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIDDK NIH HHS, NIDDK, Beatson Foundation.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Förderung
- NIDDK NIH HHS
- NIDDK
- Beatson Foundation
- Diabetes Research & Wellness Foundation
Zitieren
APA
Cheruiyot, A., Hollister-Lock, J., Sullivan, B., Pan, H., Dreyfuss, J. M., Bonner-Weir, S., & Schaffer, J. E. (2023). Sustained hyperglycemia specifically targets translation of mRNAs for insulin secretion. Journal of Clinical Investigation, 134(3). https://doi.org/10.1172/jci173280
Vancouver
Cheruiyot A, Hollister-Lock J, Sullivan B, Pan H, Dreyfuss JM, Bonner-Weir S, et al. Sustained hyperglycemia specifically targets translation of mRNAs for insulin secretion. Journal of Clinical Investigation. 2023;134(3). doi:10.1172/jci173280
BibTeX
@article{Cheruiyot2023,
author = {Cheruiyot, Abigael and Hollister-Lock, Jennifer and Sullivan, Brooke and Pan, Hui and Dreyfuss, Jonathan M and Bonner-Weir, Susan and Schaffer, Jean E},
title = {Sustained hyperglycemia specifically targets translation of mRNAs for insulin secretion},
journal = {Journal of Clinical Investigation},
year = {2023},
volume = {134},
number = {3},
doi = {10.1172/jci173280}
}
EUVIMED